Mkt Cap$2.17T+2.22%
24h Vol$85.42B
BTC Dom55.6%
ETH Dom9.0%
F&G12Extreme Fear
BTC$60,312.00+2.08% ETH$1,613.22+3.41% USDT$0.9986+0.00% BNB$560.05+2.26% USDC$0.99970.00% XRP$1.06+1.91% SOL$75.18+6.67% TRX$0.3213-0.18% FIGR_HELOC$1.05+2.60% HYPE$66.74+9.75% DOGE$0.0735+1.16% RAIN$0.0159+2.62% USDS$0.9996+0.01% LEO$9.56+1.43% ZEC$407.48+10.28% XLM$0.1754+2.78% BTC$60,312.00+2.08% ETH$1,613.22+3.41% USDT$0.9986+0.00% BNB$560.05+2.26% USDC$0.99970.00% XRP$1.06+1.91% SOL$75.18+6.67% TRX$0.3213-0.18% FIGR_HELOC$1.05+2.60% HYPE$66.74+9.75% DOGE$0.0735+1.16% RAIN$0.0159+2.62% USDS$0.9996+0.01% LEO$9.56+1.43% ZEC$407.48+10.28% XLM$0.1754+2.78%
News

Market Analysis

Total Stories
2,802
Section
Market Analysis
Why did Sonnet Therapeutic's Shares Gain over 200% in Today's Premarket Trading?
Market Analysis

Why did Sonnet BioTherapeutics (SONN) Shares Gain over 200% in Premarket Trading?

Sonnet BioTherapeutics announced an $888 million business combination to create Hyperliquid Strategies Inc, a public cryptocurrency treasury company.

Tim FriesJul 14, 20253 min read